Angina Pectoris Clinical Trial
Official title:
Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics
The investigators will compare myocard vitality diagnostics using 2D-Strain echography and MRI.
Each patient with typical angina pectoris symptoms will get echocardiographic examination
during the inclusion phase. If motion disorder of regional left ventricular myocardial wall
is detected, patient will get coronary angiography (not study related, caused of typical
angina pectoris symptoms and high probability of CHD). If coronary stenosis related to
motion disorder is available, patient will be randomized in two groups during coronary
angiography.
- First Group: Patient will get echocardiographic examination during coronary
angiography. 2D-Strain Analysis will be performed based on data of this
echocardiographic examination. Only when vitality in the contraction impaired segments
will be established based on 2D-Strain Analysis, PCI (Percutaneous Coronary
Intervention) will be performed.
- Second Group: Coronary angiography by patient will be canceled. Patients will get
viability assessment using MRI(Magnetic resonance imaging) within the next 7 days. When
vitality will be established with MRI, patient will get PCI (Percutaneous Coronary
Intervention).
In addition, as part of a feasibility analysis, the possibility of a consolidation of data
of coronary angiography with the ultrasound images will be researched by first group of
patients. The aim is to simplify the visualization of the intraprocedural vitality
detection. For this purpose, a position sensor based on electromagnetic fields (EMT) will be
used during coronary angiography.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT02773615 -
CT Perfusion Added to CT Angiography
|
||
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Terminated |
NCT02548611 -
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
|
Phase 4 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Completed |
NCT02440893 -
Understanding the Effect of Metformin on Corus CAD (or ASGES)
|
||
Completed |
NCT01486030 -
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
|
||
Completed |
NCT01425359 -
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
|
Phase 4 | |
Completed |
NCT01604486 -
Natural Ischaemic Preconditioning Before First Myocardial Infarction
|
N/A | |
Completed |
NCT00811772 -
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
|
N/A | |
Completed |
NCT00131183 -
Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina
|
Phase 4 | |
Completed |
NCT00184444 -
Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients
|
N/A | |
Completed |
NCT00235404 -
Randomized Controlled Trial of Health Care to Elderly Patients.
|
N/A | |
Terminated |
NCT00157742 -
Comparison of SCS and PMR in Patients With Refractory Angina Pectoris
|
Phase 4 | |
Completed |
NCT00000510 -
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
|
Phase 3 | |
Completed |
NCT00005148 -
Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships
|
N/A | |
Not yet recruiting |
NCT03657758 -
Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]
|
Phase 4 | |
Completed |
NCT05050773 -
Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)
|
||
Completed |
NCT00093223 -
A Safety Study of ABI-007 for In-Stent Restenosis
|
Phase 2 | |
Active, not recruiting |
NCT02508714 -
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
|
N/A |